HOLLYWOOD, Fla. — While there is not yet definitive evidence that vascular closure devices produce better outcomes than manual compression, their use appears appropriate in most procedures with ...

Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...

New data presented Saturday at TCT 2014 show that, in patients undergoing transfemoral coronary angiography, vascular closure devices match manual compression in terms of vascular access site ...

In an analysis of the ISAR-CLOSURE trial, use of vascular closure devices was as safe and effective as manual compression for artery closure in women undergoing transfemoral angiography. Researchers ...

- Passive approximators segment, femoral access segment are set to lay claim to a sizeable share of the market under the product and access type category, respectively - Asia-Pacific (APAC) will ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. The major drivers for this market include the large number of approvals for vascular closure devices, the high ...

BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...

Vascular closure devices market is expected to reach $984.6 million from $704.8 million, at a CAGR of 6.9% from 2016-2021.Major drivers include large number of approvals for vascular closure devices, ...

Earlier this week, Needham downgraded Haemonetics from “Buy” to “Hold,” pointing to intensifying competition in vascular closure devices from Abbott and Cordis and warning that this could weigh on the ...

NEW YORK, Oct. 29, 2019 /PRNewswire/ -- Vascular Closure Device market worldwide is projected to grow by US$413.8 Million, driven by a compounded growth of 6.6%. Passive Approximators, one of the ...

Chicago, IL - A new vascular closure device with a bioabsorbable plug has shown impressive results in a pivotal multicenter trial, ECLIPSE. The device, named ExoSeal (Cordis), also has a unique ...

DUBLIN--(BUSINESS WIRE)--The "Vascular Closure Device Market | US | Units Sold, Average Selling Prices, Forecasts | 2018-2024 | MedCore" report has been added to ResearchAndMarkets.com's offering.